X4 Pharmaceuticals Inc (NASDAQ:XFOR) price on Thursday, November 14, rose 47.85% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.41.
A look at the stock’s price movement, the close in the last trading session was $0.28, moving within a range at $0.305 and $0.4928. The beta value (5-Year monthly) was 0.388. Turning to its 52-week performance, $1.60 and $0.26 were the 52-week high and 52-week low respectively. Overall, XFOR moved -23.08% over the past month.
X4 Pharmaceuticals Inc’s market cap currently stands at around $69.08 million, with investors looking forward to this quarter’s earnings report slated for in December.
Analysts have a consensus estimate of 3.15M for the company’s revenue for the quarter, with a low and high estimate of 1.22M and 4.75M respectively.
Turning to the stock’s technical picture we see that short term indicators suggest on average that XFOR is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend XFOR as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
XFOR’s current price about -20.96% and -29.95% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 40.39, while 7-day volatility ratio is 38.12% and 15.20% in the 30-day chart. Further, X4 Pharmaceuticals Inc (XFOR) has a beta value of 0.30, and an average true range (ATR) of 0.08. Analysts have given the company’s stock an average 52-week price target of $3, forecast between a low of $3 and high of $5. Looking at the price targets, the low is -631.71% off current price level while to achieve the yearly target high, price needs to move -1119.51%. Nonetheless, investors will most likely welcome a -631.71% jump to $3 which is the analysts’ median price.
If we refocus on X4 Pharmaceuticals Inc (NASDAQ:XFOR), historical trading data shows that trading volumes averaged 3.2 over the past 10 days and 1.37 million over the past 3 months. The company’s latest data on shares outstanding shows there are 167.43 million shares.
The 30.45% of X4 Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 38.15% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 11.42 million on 2024-10-31, giving us a short ratio of 8.64. The data shows that as of 2024-10-31 short interest in X4 Pharmaceuticals Inc (XFOR) stood at 684.0 of shares outstanding, with shares short falling to 13.56 million registered in 2024-09-30. Current price change has pushed the stock -51.10% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the XFOR stock continues to rise going into the next quarter.
